Life After a GLP-1: What the Research Says About Keeping the Weight Off

This is the part of the conversation almost nobody is having, and it is the part I care about most. Enormous attention goes to starting these medications and almost none to what happens after. If you are on one now, or thinking about a taper, or already off and watching the scale creep, this is for you.

The Number You Should Know

In the extension phase of a large semaglutide trial, participants who had lost an average of 17.3 percent of their body weight over 68 weeks discontinued treatment. One year later they had regained roughly two-thirds of what they lost, ending at a net 5.6 percent below where they started1. A 2026 systematic review and meta-regression pooling data across this class reached the same conclusion: people who discontinue regain the majority of the weight lost during treatment2.

I do not share that to be discouraging. I share it because knowing it changes what you do while you are still on the medication, and that window is where the leverage is.

Why Regain Happens

Two forces, working together.

The first is appetite. These medications suppress it pharmacologically. Remove the medication and the underlying appetite signaling returns, often forcefully. That is not a character failure. That is physiology doing exactly what it was always going to do.

The second is body composition, and this is the one you can actually influence. Some lean tissue comes off alongside fat during any significant weight loss. Muscle is metabolically active, so losing it lowers the calories you burn at rest. If you finish a weight loss phase with meaningfully less muscle than you started with, you return to normal appetite with a lower energy requirement. That is a difficult combination, and it is largely why the regain curve looks the way it does. The literature on discontinuation specifically flags loss of lean body mass and reduced resting metabolic rate among the mechanisms driving it2.

What Actually Protects the Outcome

Build the Habit Before You Need It

The single most useful thing I can tell you: the maintenance phase is won during the treatment phase. If you spend eighteen months eating very little because your appetite is suppressed, and you never build a protein habit or a training habit, then the day the medication stops you have no infrastructure to fall back on. Treat the months on the medication as the time to build the eating pattern you intend to keep.

Protein Is the Anchor

Guidance for adults losing weight on these medications lands at 1.2 to 1.6 grams of protein per kilogram of body weight daily3. Protein does two jobs here. It supplies the material for maintaining lean mass, and it is the most satiating macronutrient, which matters enormously once pharmacological appetite suppression goes away. A mug of bone broth protein is a low-effort way to hold the habit steady through the transition.

Resistance Training Is Not Optional

A published case series followed patients who prioritized lean tissue preservation with resistance training three to five days a week alongside higher protein intake. They lost substantial fat while holding lean soft tissue steady or gaining it4. That is the body composition you want to be carrying into a maintenance phase. For more on why this matters increasingly with age, see my piece on age-related muscle loss.

Do Not Let Nutrition Slip

Reduced intake over a long period means reduced intake of everything, and shortfalls in vitamin D, B12, iron, and calcium are documented concerns in this population5. Walking into a maintenance phase already depleted makes everything harder. A daily multivitamin is reasonable insurance, though bloodwork is better than guessing.

A Note on Tapering

Whether to stop, taper, or continue is a medical decision, full stop. It belongs to you and the physician who prescribed it, and it depends on your health history, your reason for starting, and factors no article can assess. What I would encourage is having the conversation deliberately rather than letting the decision be made for you by a lapsed prescription or an insurance denial. Going in with a plan produces better outcomes than going in by accident.

The Reframe I Would Offer

Obesity behaves as a chronic condition, and the regain data reflect that rather than reflecting anything about your willpower. What that means practically is that the goal was never to lose weight and be finished. The goal is to arrive at a stable weight carrying as much lean tissue, and as many durable habits, as you can. Protein and resistance training are how you get there, and they work whether you stay on the medication or come off it. For more on how protein needs change over time, see protein's role in weight loss and aging. Results may vary from person to person.

Frequently Asked Questions

How much weight do people regain after stopping a GLP-1?

In the extension phase of a large semaglutide trial, participants regained roughly two-thirds of their lost weight within a year of discontinuation, ending at a net 5.6 percent below baseline after having reached 17.3 percent. A 2026 meta-regression across this class reached similar conclusions. Individual outcomes vary considerably.

Why does weight come back after stopping the medication?

Two factors combine. Appetite suppression ends when the medication does, so underlying hunger signaling returns. Separately, lean tissue lost during the weight loss phase lowers resting metabolic rate, meaning fewer calories burned at rest. The literature identifies both reduced lean mass and metabolic adaptation among the drivers of regain.

Can you prevent weight regain after a GLP-1?

No approach fully prevents regain, but protein intake and resistance training have the strongest supporting evidence for protecting lean mass and supporting satiety. Building those habits during the treatment phase, rather than after it, appears to matter most. Discuss any plan to stop or taper with your prescribing physician.

How much protein should you eat during the maintenance phase?

Clinical guidance for adults losing weight on these medications suggests 1.2 to 1.6 grams of protein per kilogram of body weight daily. Protein supplies material for lean mass and is the most satiating macronutrient, which becomes especially relevant once pharmacological appetite suppression ends. Talk with your doctor about the right target for you.

Does Bone Broth Protein help during a GLP-1 transition?

Bone Broth Protein is a way to hold a daily protein habit steady in a format many people find easy to keep up. Many customers report that a warm mug is simpler to maintain than preparing an equivalent amount of solid food. It supports a protein target rather than acting on weight directly, and results may vary.

Should you taper off a GLP-1 gradually?

Whether to stop, taper, or continue is a medical decision that depends on your health history and your reason for starting. It should be made with the physician who prescribed the medication. Having that conversation deliberately tends to produce better outcomes than an unplanned stop from a lapsed prescription or coverage change.

Does resistance training help keep weight off after a GLP-1?

A published case series of patients who combined resistance training three to five days a week with higher protein intake reported substantial fat loss alongside lean soft tissue that was maintained or increased. Carrying more lean tissue into a maintenance phase supports resting metabolic rate. Individual results vary.

Do you still need supplements after stopping a GLP-1?

Extended periods of reduced intake can leave shortfalls in nutrients including vitamin D, B12, iron, and calcium, which are documented concerns during this kind of weight loss. Entering a maintenance phase already depleted makes the transition harder. Bloodwork from your doctor is more useful than supplementing on assumption.

References

1. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564. (Industry-funded trial.) https://pubmed.ncbi.nlm.nih.gov/35441470/

2. Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression. eClinicalMedicine. 2026. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00043-X/fulltext

3. Medical nutrition in the glucagon-like peptide-1 (GLP-1) era: Protein strategies, micronutrient monitoring, and lean mass preservation. Clinical Nutrition ESPEN. 2026. https://www.sciencedirect.com/science/article/abs/pii/S2405457726004018

4. Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12536186/

5. Bridging the nutrition guidance gap for GLP-1 receptor agonist therapy assisted weight loss: lessons from bariatric surgery. International Journal of Obesity. 2026;50:265-267. https://www.nature.com/articles/s41366-025-01952-w

6. Aussieker T, Hilkens L, Holwerda AM, et al. Collagen Protein Ingestion during Recovery from Exercise Does Not Increase Muscle Connective Protein Synthesis Rates. Medicine & Science in Sports & Exercise. 2023;55(10):1792-1802. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487367/